chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Caller mentioned that she took the new vaccine and was wanting to know which medicine would be best to reduce pain in the arm.; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Caller mentioned that she took the new vaccine and was wanting to know which medicine would be best to reduce pain in the arm.) in a female patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Caller mentioned that she took the new vaccine and was wanting to know which medicine would be best to reduce pain in the arm.). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Caller mentioned that she took the new vaccine and was wanting to know which medicine would be best to reduce pain in the arm.) outcome was unknown.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.       No concomitant medication was reported.  Patient wanted to know which medicine would be best to reduce pain in the arm and if she can take Advil.   Reporter did not allow further contact
Had spinning in the head followed by pain in the throat. The pain in throat gradually got severe. Now my Doctor found me to have thyroditis.  Two weeks after vaccination had a mammogram done and they said the lymphnodes were swollen
pt recv vax in 1995 & devel an inj site rxn,characterized by redness & induration;this is one of seven patients from this site who exp the above rxn;
I received my first Covid-19 shot by Pfizer on January 23, 2022. Upon receiving the shot, I immediately felt discomfort in my chest, which slowly disappeared throughout the day.        The following day on January 24, 2022 around 1300, I began to suffer from tachycardia for 5 hours with a resting heart rate of 110BPM, sharp pains in my heart upon fast exerted movement, and mild SOB. After those symptoms subsided, I ended the night with the normal vaccine side effects of fever, fatigue, and weakness.        For the next 3 days, I continued to suffer from dull pain in my left chest, and continuous sharp pains from fast exerted movements. I stopped exercising and stopped my caffeine intake to be sure.        On January 26,2022, the next day, the pain was still lingering and I still could not exercise.        Even to this day (Day 6 - Saturday January 29, 2022), I had relief from the anti-inflammatory shot I received in ER and I can now exercise and exert forced movement, however, I still continue to deal with the dull pain in the left side of my chest. I still cannot do ab workouts due to pain.
Admitted to hospital on 10/2 with covid pneumonia with acute hypoxia respiratory failure.  Also stated history of having bright red bleeding per rectum. Treated with covid bundle medications. Intubated on 10/4 due to Upper airway obstruction due to large volume posterior aspect epistaxis. Internal maxillary artery embolization on 10/7 but continued to have anemia and thrombocytopenia with continued melanotic stool and suctioning of bleeding in the setting of severe sepsis. Received 9 units platelets and over 3 units PRBC.  Diagnosed with bilateral sub segmental PEs but not candidate for anticoagulation due to bleeding risk. Evidence of rhabdomyolysis  with AKI.  Treated with cefepime and zyvox due to sepsis and shock. Coagulopathy continued with cyanosis of the upper and lower digits. Decreased pulsations in the dorsal pedis and upper extremities.  Ultrasound showed no flow in right dorsalis pedis and dampened flow in right and left ulnar arteries. Given prophylactic anticoagulation due to bleeding risk. Mucosal bleeding increased. A=complicated course with encephalopathy and unable to be weend from vent.  Family aware and transitioned to comfort care.
Numbness in left hand; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 01May2021 at 14:30(at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Patient had no known allergies. The patient received other medications in two to three weeks, names unspecified. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 18:00, the patient experienced numbness in left hand. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event numbness in left hand was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Gave vaccine at 12:30 pm. Adverse reaction started at 5:00pm. Cough, wheezing, chest tightness, drop in blood pressure, loss of color in face and shortness of breath.
itching at site, swelling and redness and site was very hot to touch, started immediately after injection and worsened took a Benadryl after a half an hour and symptoms resolved within several hours.
Approximately 10 minutes after vaccine administration, patient complained of dizziness, and remained seated in the pharmacy vaccine area to wait for improvement.  The patient was checked on a few minutes later, where her symptoms had worsened to include an elevated heart rate.  A blood pressure was checked and found to be elevated.  Patient remained stable but developed some throat discomfort and a slight difficulty in swallowing.  Patient reported no itching, rash, swelling or difficulty breathing.  Symptoms did not improve, and EMS was called.  Patient's pulse was 89 and oxygen saturation was steady at 99% when checked by first responders.  The patient decided to leave under her own power with paramedics for further evaluation.  Upon follow up with the patient later the same day, she reported an improvement in her condition.
immunization given 12/6/2019 seen 2/3/20 c/o recurrent swelling and pain at injection site on LT upper arm since 12/6/2019.
I experienced after 10 minutes, racing heart, stomach cramping, tingling, shortness of breath, diarrhea, dizziness, which lasted 4 to 5 hours. After a few days my Lyme Disease symptoms increased to a flare up with headaches, flushing, tachycardia which lasted for 2 months before resolving.
Patient was given vaccine on 9/18/23. When billing was processed, insurance said patient already had flu vaccine on 8/30/23.
Pt developed diffuse myelitis 30 days post vaccines. No infectious cause identified to date.
Pt contacted RN this morning reporting not feeling well following Pfizer #2. Reports when at work last evening developed hives and itching, took a Benadryl and received relief. Reports she developed dizziness, HA, nausea and vomiting. Left work per manager's advise. This morning reports nausea, diarrhea, achiness and fatigue. Employee reports no recent known exposure to COVID. Pt scheduled for video visit this morning with provider.
red bumps on both of their arms where the injection site was; the lady who administered the vaccine did not go deeper in injecting the vaccine; This is a spontaneous report from a Pfizer-sponsored program via a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (BNT162B2, formulation; Solution for injection), via an unspecified route of administration, administered in unspecified Arm on 01Sep2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter stated that the lady who administered the vaccine did not go deeper in injecting the vaccine and could have been an error on administration on 01Sep2021. Since today, 02Sep2021, the patient experiencing really red bumps on both of their arms where the injection site was. The outcome of event red bumps on both of their arms reported as unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Quick onset of symptoms on 2/18/2021, immediately following intense outdoor activity :snowshoeing in the cold for 1 hour.  Symptoms were: severe headache, nausea, fever of 101, significant body aches. Symptoms  lasted for 18 hours. I reached out to my primary care internist inquiring if I was allowed to self administer Tylenol and Advil to get relief.  I did not go into a clinic. I self administered  Advil every 4 hours. I received relief.
had a really sore arm; advised that if the rash doesn't seem to get better over next few weeks or worsens it could be due to vaccine; chills; fever; This spontaneous case was reported by an other (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (had a really sore arm), RASH (advised that if the rash doesn't seem to get better over next few weeks or worsens it could be due to vaccine), CHILLS (chills) and PYREXIA (fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (had a really sore arm), RASH (advised that if the rash doesn't seem to get better over next few weeks or worsens it could be due to vaccine), CHILLS (chills) and PYREXIA (fever). At the time of the report, PAIN IN EXTREMITY (had a really sore arm), CHILLS (chills) and PYREXIA (fever) had resolved and RASH (advised that if the rash doesn't seem to get better over next few weeks or worsens it could be due to vaccine) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient spoke with a pharmacist and stated he was planning to get the second dose of Moderna vaccine that same day and the pharmacist advised the patient to space out his treatment with Dupixent about one week from the vaccine. It is unknown at the time of this report if treatment with Dupixent had already been initiated or if it was first dispensed during this encounter with the pharmacist. The pharmacist stated other patients had reported symptom flare up after receiving COVID vaccines. The patient was advised by the pharmacist that if the rash did not get better over the next few weeks or if it worsened, it possibly could be due to the vaccine. The patient stated he had a really sore arm, fever, and chills with the first dose of COVID vaccine.  No treatment information was provided regarding events of sore arm, fever, and chills. Treatment for the rash is currently unknown.
felt like death on a cracker; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt like death on a cracker) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (felt like death on a cracker). At the time of the report, FEELING ABNORMAL (felt like death on a cracker) outcome was unknown.      No Concomitant information was reported.  No Treatment information was reported.   This case was linked to MOD-2022-505816 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 08-Mar-2022: Non-significant follow up appended due to email doc attached to the initial version.
No adverse event; Patient received 0.25 ml vaccine for 6 months to age 5 year; Patient received 0.25 ml vaccine  instead of 0.5 ml vaccine; This spontaneous case was reported by a physician and describes the occurrence of INCORRECT DOSE ADMINISTERED (Patient received 0.25 ml vaccine for 6 months to age 5 year), ACCIDENTAL UNDERDOSE (Patient received 0.25 ml vaccine  instead of 0.5 ml vaccine) and NO ADVERSE EVENT (No adverse event) in an 8-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 10-Oct-2022, the patient experienced INCORRECT DOSE ADMINISTERED (Patient received 0.25 ml vaccine for 6 months to age 5 year) and ACCIDENTAL UNDERDOSE (Patient received 0.25 ml vaccine  instead of 0.5 ml vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (Patient received 0.25 ml vaccine for 6 months to age 5 year), ACCIDENTAL UNDERDOSE (Patient received 0.25 ml vaccine  instead of 0.5 ml vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for INCORRECT DOSE ADMINISTERED (Patient received 0.25 ml vaccine for 6 months to age 5 year) and ACCIDENTAL UNDERDOSE (Patient received 0.25 ml vaccine  instead of 0.5 ml vaccine).    Concomitant medication was not provided.  Treatment information was not provided.
still has a strong pain at the injection site; 3 weeks ago it started to swell his right leg from his knee to his foot thumb; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (still has a strong pain at the injection site) and PERIPHERAL SWELLING (3 weeks ago it started to swell his right leg from his knee to his foot thumb) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (still has a strong pain at the injection site) and PERIPHERAL SWELLING (3 weeks ago it started to swell his right leg from his knee to his foot thumb). At the time of the report, VACCINATION SITE PAIN (still has a strong pain at the injection site) and PERIPHERAL SWELLING (3 weeks ago it started to swell his right leg from his knee to his foot thumb) outcome was unknown.            No concomitant medication was provided by the reporter.  No treatment medication was reported.   Reporter did not allow further contact
On 12/31/21, 11 days after taking the Moderna Booster I noticed large red spots around my waste and chest. That evening I thought it might be poison ivy or something as I have never had any type of reaction like this before, unless it was poison ivy. So I put calamine lotion on and went to bed. In the morning the spots calmed down and were almost gone, so I thought there is no way it was poison ivy. That day I got more and more spots that were red and as I would itch them you would see the scratch marks and the entire area would get really red and some spots would get hives if I scratched a lot. At that point I started taking Benadryl, which I don't recall taking my entire life.  Also, continuing to put calamine location on so the areas didn't get too red and hive up. This would go on throughout the day and would take 2 Benadryl at night, which seemed to knock me out. To my surprise those areas would be gone in the morning. However, throughout the following day new areas would pop up. This has continued for weeks and through video doctors appointments and in person I still have reactions pop up through the day. The session is about to time out or I would write more.
Vaccine administered after use by date. Efficacy study done by Moderna and vaccine deemed effective and no re-vaccination needed.
PATIENTS DAUGHTER CALLED STATING "MY MOTHER DEVELOPED CELLULITIS AT VACCINE ADMINISTRATION SITE AND WAS SEEN IN THE EMERGANCY ROOM FOR THIS PROBLEM".  "MY MOTHER WAS TREATED WITH KEFLEX 500 MGM BID X 10 DAYS FOR THIS".
Little Shivers After Second Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Little Shivers After Second Vaccine) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 039K20A) for COVID-19 vaccination.     The patient's past medical history included Obesity. Concurrent medical conditions included Blood pressure high since 2004, Arthritis in 2000 and Seasonal allergy. Concomitant products included NAPROXEN for Arthritis, LOSARTAN for Blood pressure, OMEPRAZOLE for Heartburn, LEVOTHYROXINE for Hyperthyroidism, CLARITHROMYCIN for Seasonal allergy.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHILLS (Little Shivers After Second Vaccine). On 06-Mar-2021, CHILLS (Little Shivers After Second Vaccine) had resolved.            No treatment details were provided by the reporter.   This case was linked to MOD-2021-026217 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Nonsiginificant Follow up included no new significant information. On 27-Jul-2021: Additional information included current conditions like blood pressure, obesity, arthritis and also included concomitant medications such as losartan , levothyroxine, naproxen, omeprazole, clarithromycin and reporter information.
Generalized body aches, headache, stomach upset, sweating, sore throat, slight cough and rhinorrhea.
24 y/o received the Moderna booster on 12/23//21 @ around 1000 am. After setting for about 10, he became confused, and disoriented. He then stated he began to tingle and passed out. Originally his blood pressure was 210/106, pulse rate was 167 respiration was 24 breaths per minute and non labored.  We placed him in a supine position with a cold pack on the back of his neck till he woke back up. His vitals were taken again and were as follows: blood pressure 118/48, respiration 18 non labored, pulse rate of 78,  and his 02 saturation was at 97, the event lasted approximately 10 min, and afterwards his wife took him to the local hospital.
Patient received the covid vaccine on 12/22/2020.   c/o new onset of HA and dizziness at the same time. Hx of HTN, DM, "autoimmune" disorder on MTX.  BP is well controlled with medication 140s/80s One day after the vaccination, her BP was 172/92 HR 69.  She continues to have HAs and dizziness. Denies heart palpitations, fever, chills, blurred vision, cough, chest discomfort, or SOB.  She is concerned if the pfizer vaccine is interacts with her MTX. Covid test on 12/29/2020 was negative.
Given DTaP, IPV, MMR and varicella on 3/1/06. Rash on arm where IPV, varicella administered started 3/11/06. Rash red with small blisters within rash. Presumed from varicella vaccine
HYPOXIA 2/4/2022 ATRIAL FIBRILLATION, UNSPECIFIED  HYPOXIA 2/4/2022 SPONDYLITIS OF LUMBOSACRAL SPINE
I developed a rash about 6 inches long and 3 inches wide (long oval). The first rash developed 6 days after vaccination and went away about 5 days later. The second vaccination was this past Saturday and the rash developed the following day and is worsening at this time (which is the trajectory of the last rash before it healed). I also experienced cold extremeties about 2 weeks after the first dose.
(R) deltoid pain-always aware of it being sore has a knot in deep tissues has stabbing pain. Achiness.
LD, large red area.  Swollen-warm to touch.  Complained of soreness approx. 2in reddened area.
This spontaneous report was received from a licensed vocational nurse and refers to a multiple unknown patients of unknown age and gender. The patients' medical history and concurrent conditions were not reported. On an unknown date, during an unspecified two week period, the patients were vaccinated with improperly stored GARDASIL (lot # K011325, expiry date: 08-APR-2017 and K011562, expiry date: 08-APR-2017) (doses and route of administration were not reported). No concomitant therapy was reported. Temperature excursion was 32 degree of Fahrenheit through 7 days during 2 weeks period. There was no previous temperature excursion. Data logger was involved. No adverse effect was reported. This is one of several reports from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA006826.
This spontaneous report was received from a registered nurse concerning an unspecified patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 injection, lot number L018503; expiration date 16-MAR-2017, lot number M036728; expiration date: 20-MAY-2018, lot number M037669; expiration date: 09-MAY-2018, lot number M042599; expiration date: 17-JUN-2018, or lot number M042785; expiration date: 17-JUN-2018 (strength, dose and route of administration were not reported) for prophylaxis. The temperature excursion with PNEUMOVAX 23 was 30 minutes between 9 to 25 Celsius degrees. There was no previous temperature excursion. The temperature excursions were detected by a data logger. No adverse effects were reported and no product quality complaint (PQC) was involved. This is one of several cases from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1703USA009373: US-009507513-1703USA005140: US-009507513-1703USA009372.
Headache  Nauseous  Body Aches 4 days after injection red itchy rash that moved from the injection site to the elbow. Used topical antihistamine cream to relieve itch.  Disappeared within one week.
Developed cough & chest congestion 8/1/21, progressively worsening. Admitted to  hospital 8/17/21, COVID positive. Patient states vaccinated in February. Hypoxemia, continued to worsen. Transfer to ICU 8/27, placed on BIPAP, intubated 8/30/21. Made DNR 9/9/21.
Information has  been received from a agency on 22-JUL-2010.  On 30-Jun-2010, a pregnant female received 0.5 ml H1N1 with an expiration date of 30-Jun-2010.  There were no complaints of adverse events.  The agency reported that the pharmacy did not supply or administer the expired vaccine.  Information will be obtained from the nurse by the agency.  Additional information has been requested.  Information derived from this AE report does not change the current safety profile of the product.
On Monday April 12th I woke in the morning not feeling myself, I noticed that i had no feelimh on the right side of my face and no control on the left side of my face  I went to the hospital because I wanted to be sure thatI was not suffering from a stroke. they ran testes. it was con firmed that i did suffer a stroke, but i was in fact suffering from Bells Palsy. Now I have never had Bells PAlsy in my life and was made aware that this could happen out of no where but hey also indicated if i had done anything out of the ordinary. In that case I was still within my five day window of receiving my 1st Pfizer vaccine.